Hyperfine begins commercial launch of Optive AI

Hyperfine has begun the commercial launch of its latest Optive AI software used on its Swoop portable MRI system for brain imaging.

Optive AI improves each stage of the imaging process, from noise cancellation and image acquisition to reconstruction and postprocessing, the company said. Hyperfine has begun rolling out the new software to hospitals and outpatient neurology offices in the U.S., with plans to bring it to all current customers in the coming weeks.

Optive AI -- the tenth version -- was cleared in the U.S. in May 2025 and is also available for commercial use in Canada, Australia, and New Zealand, Hyperfine noted.